House of Commons
EDM #980
Tabled 26 February 2018
2017-19 Session
That this House expresses grave concern over proposed changes to NICE guidelines on the recognition and management of depression in adults, which could have a profoundly detrimental impact on patient care and access to effective treatments; notes the concerns expressed by several respected clinical leaders and professional bodies that the current draft guideline, published in July 2017, is underpinned by a flawed methodology for establishing whether or not a treatment is effective which is out of step with US and European guideline methodologies; believes that national clinical guidelines on depression should properly reflect the evidence base and the weight of scientific and medical opinion; and calls on NICE to grant a second stakeholder consultation to ensure that the views of clinicians, professional bodies and patient organisations are adequately reflected in the final guidelines.